Publications
5808 Results
- Journal / Conference
- International Journal of Radiation Oncology, Biology, Physics 87(4):638-645
- Year
- 2013
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID24035327
- PMC
- PMC3938865
- Study Number(s)
- R9811
Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial
- Journal / Conference
- Annals of Surgical Oncology 20(8):2787-2795
- Year
- 2013
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID23435609
- PMC
- PMC5600517
- Study Number(s)
- CTSU/A021101
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design
- Journal / Conference
- New England Journal of Medicine 369(20):1968
- Year
- 2013
- Research Committee(s)
- Cancer Control
- PMID
- PMID24224632
- PMC
- PMC4927191
- Study Number(s)
- SWOG-9217
Survival in the prostate cancer prevention trial
- Journal / Conference
- Journal of Thoracic Oncology 8(suppl. 2): abstr. MO13.01; the 15th World Conference on Lung Cancer, October 2013, Sydney, Australia
- Year
- 2013
- Research Committee(s)
- Lung
- Study Number(s)
- S0327, S0435, S0802
Disease control rate at 8 weeks predicts subsequent survival in platinum-treated extensive stage small cell lung cancer (ES-SCLC): a patients level analysis of SWOG trials
- Journal / Conference
- Breast 22(5):606-615
- Year
- 2013
- Research Committee(s)
- Cancer Survivorship
- PMID
- PMID24007941
- PMC
- (reviews not within scope of Public Access Policy)
Supportive care after curative treatment for breast cancer (survivorship care): Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement
- Journal / Conference
- Journal of Urology 2013 Jul;190(1):70-76
- Year
- 2013
- Research Committee(s)
- Cancer Control
- PMID
- PMID23313212
- PMC
- PMC3708069
- Study Number(s)
- SWOG-9217
The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculator
- Journal / Conference
- Urology 79(3):633-637
- Year
- 2012
- Research Committee(s)
- Genitourinary
- PMID
- PMID22386416
- PMC
- PMC3839235
- Study Number(s)
- SWOG-9109
Ten year follow-up of neoadjuvant therapy with goserelin acetate and flutamide prior to radical prostatectomy for clinical T3/T4 prostate cancer: update on Southwest Oncology Group study 9109
- Journal / Conference
- Haematologica 97(6):937-942
- Year
- 2012
- Research Committee(s)
- Lymphoma
- PMID
- PMID22271896
- PMC
- PMC3366663
- Study Number(s)
- SWOG-8809, S9800, S9911
Fc gamma receptor 3a genotype predicts overall survival for follicular lymphoma patients treated on Southwest Oncology Group trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone
- Journal / Conference
- The Oncologist 17(9):1180-1190;
- Year
- 2012
- Research Committee(s)
- Cancer Survivorship
- PMID
- PMID22723506
- PMC
- PMC3448411
- Study Number(s)
- S0316
A prospective analysis of the influence of older age on physician decision-making when considering enrollment to breast cancer clinical trials (SWOG S0316)
- Journal / Conference
- Cancer 118(3):770-776, 2012;
- Year
- 2012
- Research Committee(s)
- Sarcoma
- PMID
- PMID21751200
- PMC
- PMC3576704
- Study Number(s)
- S0505